News

Given its better valuation, we believe that Pfizer stock (NYSE: PFE) is currently a better pick than its industry peer …

Pfizer is slowly starting to replace its COVID-19 portfolio with newer medicines. Snap's strong ecosystem could allow it to eventually …

Pfizer has an attractive valuation due to two key factors. The drugmaker has multiple growth drivers in its lineup and …

The Phase 2 trial was evaluating the vaccine called VLA15 following a second booster dose given one year after the …

Stock market prices don't tell you everything, and that's certainly true with these businesses. Pfizer is paving the way to …

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today introduced PfizerForAll, a user-friendly digital platform designed to make access to healthcare and …

BOTHELL, Wash.—At a recent company town hall here, Pfizer's cancer-business chief looked over some 100 scientists, marketers and other staffers …